XNAS · CERS
+2.69% · +$0.0800 · Vol Not reported
Pre-market · updated 04:09:25 ET
Cerus Corp

Cerus Corp

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$3.05
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
CERS
Cerus Corp
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

88/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CERS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CERS catalysts
About Cerus Corp
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
1997
Employees
345
Country
US

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.97
Last session
Day high
$2.97
Last session
Day low
$2.97
Last session
Previous close
$2.97
52W high
$3.28
-7.01% from high
52W low
$1.16
89% of range
Market cap
$600.5M
Beta
0.64
Shares out
201.5M
Avg volume
2.7M
VWAP
$2.97
Last session
Price history computed in-house
1W
+18.91%
1M
-2.56%
3M
+13.38%
1Y
+144.00%
YTD
+48.06%
SMA 50 $2.80 · above
SMA 200 $2.29 · above
52W position 89%

CERS overview

Veridion Score
88
Daily close · 2026-08-17
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CERS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CERS Form 4 filings
Public disclosures

Congress activity in CERS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CERS in the cached public ledger.

Federal contracts

CERS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CERS in this window.
Lobbying spend

CERS lobbying filings, year to date.

Registered lobbying filings matched to Cerus Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CERS in this window.
Loading news for CERS
Analyst ratings
Sovereign unlock shows live analyst consensus for CERS.
Options
Sovereign unlock shows live options positioning for CERS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.